...

Smoking is a risk factor for biochemical recurrence of prostate cancer (PCa) following radical prostatectomy (RP), new study findings suggest.

In a retrospective study of 6,538 PCa patients who underwent RP, a team led by Malte Rieken, MD, of University Hospital Basel in Basel, Switzerland, and Shahrokh F. Shariat, MD, of the Medical University of Vienna in Vienna, Austria, found that current and former smokers had a significant 1.8 and 1.6 times higher risk of biochemical recurrence than non-smokers. Smoking cessation for 10 or more years mitigated the risk. The 5-year recurrence-free survival rates for current, former, and never smokers were 83%, 84%, and 90%, respectively.

“Smokers should be counseled regarding the detrimental effects of smoking on PCa prognosis,” the investigators wrote in a report published online ahead of print in European Urology. “Urologists need to play a broader role in the health care management of our population.”

Of the 6,538 patients, 2,214 (34%), 2,086 (32%), and 2,238 (34%) were current, former, and never smokers, respectively. The median follow-up for men not experiencing biochemical recurrence was 28 months. The 3 groups were comparable with respect to Gleason score, extracapsular extension, seminal vesicle invasion, and positive surgical margins.

The researchers observed no significant association between cumulative smoking exposure and risk of biochemical recurrence.

Study limitations include the retrospective design and potential recall bias with regard to smoking history.

The new study adds to a growing body of evidence that smoking is associated with worse outcomes in patients with urologic malignancies. For example, at the recent American Urological Association annual meeting, a team led by Akshay Sood, MD, of of the Vattikuti Urology Institute, Henry Ford Hospital, Detroit, presented data showing that current and former smokers who underwent RP for PCa had increased odds of pulmonary and renal complications compared with non-smokers. Among patients who underwent radical cystectomy, current smokers had increased odds of re-intervention and former smokers had increased odds of readmission compared with non-smokers.

...

The Report Nephrology and Urology Devices Market to 2017 – Usage of Incontinence devices by the Elderly Population to Drive Market provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz

GBI Researchs report, Nephrology and Urology Devices Market to 2017 – Usage of Incontinence devices by the Elderly Population to Drive Market provides key data, information and analysis on the global nephrology and urology devices market. The report provides market landscape, competitive landscape and market trends information on three nephrology and urology devices categories Incontinence Devices, Lithotripters and Renal Dialysis Equipment.

The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape and a detailed analysis of the pipeline products in each category. The report also reviews details about important merger and acquisition deals that have taken place in the nephrology and urology devices market during the past four years.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

View Full Report at http://www.marketresearchreports.biz/analysis/3260

Scope

Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
Market size and company share data for three nephrology and urology devices market categories Incontinence Devices, Lithotripters and Renal Dialysis Equipment.
Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2009 has been given for three categories.
Qualitative analysis of key market trends, market drivers, and restraints by each category within the nephrology and urology devices market.
The report also covers information on the leading market players, the competitive landscape, and the leading technologies.
Key players covered include Fresenius Medical Care AG & Co. KGaA, Svenska Cellulosa Aktiebolaget SCA, Baxter International Inc., B. Braun Melsungen AG, Coloplast A/S, Gambro AB and Dornier MedTech GmbH.

Download Sample Copy of this Report at http://www.marketresearchreports.biz/sample/sample/3260

Reasons to buy

Develop business strategies by understanding the trends and developments that are driving the nephrology and urology devices market globally.
Design and develop your product development, marketing and sales strategies.
Exploit M&A opportunities by identifying market players with the most innovative pipeline.
Develop market-entry and market expansion strategies.
Identify key players best positioned to take advantage of the emerging market opportunities.
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
Whats the next big thing in the nephrology and urology devices market landscape? Identify, understand and capitalize.
Make more informed business decisions from the insightful and in-depth analysis of the global nephrology and urology devices market and the factors shaping it.

Table of Contents

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 8

2 Introduction 10
2.1 GBI Research Guidance 10

3 Nephrology and Urology Devices: Market Characterization 11
3.1 Global Nephrology and Urology Devices Market, Revenue ($bn), 2003 2010 11
3.2 Global Nephrology and Urology Devices Market, Revenue Forecast ($bn), 2010 2017 12
3.3 Global Nephrology and Urology Devices Market, Key Technology Trends 13
3.3.1 Wearable Artificial Kidney 13
3.3.2 Shock Wave Lithotripsy 13
3.3.3 Transurethral Microwave Thermotherapy (TUMT) 13
3.3.4 Telemedicine Improves Access to Care by Increased Efficiency and Bridging the Gap between Physician and Renal Dialysis Patients 14
3.4 Global Nephrology and Urology Devices Market, Market Dynamics 15
3.4.1 Market Drivers 15
3.4.2 Market Restraints 16
3.5 Global Nephrology and Urology Market, Key Company Share (%), 2009 18

About MarketResearchReports.biz

Marketresearchreports.biz ( http://www.marketresearchreports.biz) is the most comprehensive collection of market research reports, supporting clients’ market intelligence needs with over 100,000 market research reports, company profiles, data books, and regional market profits in its repository. We also offer consulting support for custom market research needs.Our document database is updated by the hour, which means that our customers always have access to fresh data spanning over 300 industries. From Fortune 500 companies to SMEs, Marketresearchreports.biz has built a veritable reputation for fulfilling the most exacting market research needs.

Contact:

Toll Free: 866-997-4948
(USA-CANADA)

Tel: +1-518-618-1030
E: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

...

zimmytws/iStock Photo

A 44-year-old Philadelphia man pleaded guilty to accepting kickbacks from a city… more

Another ambulance passenger entered a guilty plea tied to the federal government’s ongoing fraud probe of area ambulance companies.

During the past five years, federal authorities have charged eight Philadelphia-area ambulance companies with filing fraudulent claims that have cost the Medicare program more than $18 million.

The investigation expanded to passengers late last year year.

Home of the Day

On Tuesday, Derrick Brown, 44, of Philadelphia, pleaded guilty to charges of receiving kickbacks and making false statements to law enforcement, according to the U.S. Attorney’s Office.

Brown faces a suggested sentence of up to six months in prison followed by up to three years of supervised release. He was ordered to pay full restitution of $21.880.02.

According to the indictment filed against him, Brown, in April 2011, began receiving transportation to dialysis appointments by Philadelphia-based Brotherly Love Ambulance Inc., which billed Medicare for the trips.

Brown did not qualify for Medicare coverage because he could walk and could have been transported safely by means other than ambulance. He also accepted monthly kickbacks — the amount of which was not disclosed — from Brotherly Love Ambulance to induce him to continue to use the ambulance company for trips to the dialysis center.

Feda Kuran, the owner of Brotherly Love Ambulance, was sentenced to 64 months in prison last year for her role in the ambulance company getting Medicare to pay it more than $2 million in inappropriate claims.

Want Philadelphia Banking & Financial Services news in your inbox?
Sign up for our free email newsletters.

...